Multicenter comparison of analytical interferences of 25-OH vitamin D immunoassay and mass spectrometry methods by endogenous interferents and cross-reactivity with 3-epi-25-OH-vitamin D3

• Published in: Practical laboratory medicine Vol. 38; p. e00347
• Main Authors: Lee, Joon Hee, Seo, Jong Do, Lee, Kyunghoon, Roh, Eun Youn, Yun, Yeo-Min, Lee, Yong-Wha, Cho, Sung-Eun, Song, Junghan
• Format: Journal Article
• Language: English
• Published: Elsevier 01.01.2024
• Subjects: 3-epi-25-OH-Vitamin D3; Analytical interference; Immunoassay; Mass spectrometry; Vitamin D
• ISSN: 2352-5517; 2352-5517
• DOI: 10.1016/j.plabm.2023.e00347

BackgroundVitamin D (vit-D) deficiency is highly prevalent in the Korean population, highlighting the need for accurate measurements. In this study, the interferences by endogenous and cross-reactive substances were compared between routine vit-D immunoassays and mass spectrometry (MS) methods.MethodsTwo MS methods and 4 immunoassays from different manufacturers (Abbott, Beckman Coulter, Roche, Siemens) were compared. Residual samples that were icteric, lipemic, hemolyzed, high in rheumatoid factor, from myeloma patients, or patients undergoing hemodialysis were collected. Also, 4 levels of National Institute of Standards and Technology (NIST) Standard Reference Material 972a, and 12 samples serially spiked with 3-epi-25-OH-D3 were prepared.ResultsSignificant interferences were observed in hemolytic (Roche), icteric (Beckman and Siemens) and lipemic samples (all 4 immunoassays). Level 4 NIST material and 3-epi-25-OH-D3-spiked samples induced significant cross-reactivity, yielding higher total vit-D measurements in non-epimer-separating MS methods, and both the Beckman and Roche immunoassays.ConclusionMost observed interferences were consistent with manufacturers' claims, but overall improvement of immunoassay bias limits is required. Awareness of potential interference is important to increase the accuracy of vit-D measurements. Moreover, care is due when interpreting vit-D results of newborns, infants and less commonly, pregnant women, who are known to have physiologically high levels of the highly cross-reactive 3-epi-25-OH-D3.